Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Curcumin for Taxane-Induced Peripheral Neuropathy in Breast Cancer
IRCT20260227068964N1Phase 2Recruiting
- Sponsor
- Tabriz University of Medical Sciences
- Start
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of curcumin in chemotherapy-induced peripheral neuropathy (CIPN) and breast cancer, sponsored by Tabriz University of Medical Sciences. Started May 2026; status: recruiting.
02
Drugs
curcumin
03
Conditions
chemotherapy-induced peripheral neuropathy (CIPN)breast cancer
Beyond the preview
Go deeper on IRCT20260227068964N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260227068964N1.